Pharmafile Logo

Glaucoma in perspective

Electronic medical records and doctor/patient communication

View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.

Inizio

Statistics and bikinis – 2 men united

I want to write today about 2 men that between them have reminded me of a fine line that we have to tread every time we analyse a dataset...

Inizio

Eliminating Stigma: A consideration of the role the pharmaceutical industry can play

My recent article in Medical Marketing & Media explored the importance of vaccine perceptions in a self-pay market and touched upon the issue of stigma, with the recognition that some diseases or...

Inizio

Fighting talk

One thing that grasps my interest is how society has adopted military style language when talking about cancer

Inizio

- PMLiVE

Cancer Research UK and Medidata partner on data collection

Aim to streamline and manage data from clinical trials

Is MINT the next BRIC?

In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all...

Inizio

The healthcare market research themes for 2014

As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.

Inizio

Big Data—a new player in the Healthcare Industry

Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.

Inizio

- PMLiVE

The BMJ weighs in on Avastin/Lucentis debate

The UK’s leading medical journal says Avastin should be used for wet AMD to cut costs

- PMLiVE

ReNeuron makes shifts and additions to senior team

Including Sharon Grimster being named as general manager for Wales

- PMLiVE

Covance and Sihuan Pharma partner on portfolio development

Will collaborate on preclinical and clinical stages

- PMLiVE

Access – the only thing that matters

Our job, at its very core, is to get our medicines into the hands of patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links